Form 4: Neuronetics Director Robert Cascella Increases Stake with $102,550 Purchase
SEC Form 4 Filing
Director Robert Cascella purchased 50,000 shares of Neuronetics, Inc. at $2.051 per share, increasing his holdings.
Summary
- On June 6, 2024, Robert Cascella, a director of Neuronetics, Inc., purchased 50,000 shares of common stock.
- The purchase price was $2.051 per share.
- Following the transaction, Cascella directly owns 244,098 shares of Neuronetics, Inc.
Sentiment
Score: 6
Explanation: The sentiment is neutral to slightly positive. A director purchasing shares suggests confidence, but it's a single transaction and doesn't provide a comprehensive view of the company's overall health.
Positives
- A director's purchase of company stock can be seen as a positive signal, indicating confidence in the company's future prospects.
Industry Context
Form 4 filings are a routine part of the regulatory landscape for publicly traded companies, providing transparency into the transactions of company insiders.
Stakeholder Impact
- The stock purchase could have a slightly positive impact on shareholder sentiment.
Key Dates
| Date | Description |
|---|---|
| 06/06/2024 | Date of stock purchase transaction |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.